Coherus Oncology (CHRS) Exchange Rate Effect (2014 - 2019)
Coherus Oncology (CHRS) reported Exchange Rate Effect of -$106000.0 for Q4 2019, down 176.81% on a YoY basis from $138000.0 in Q4 2018, and down 279.66% sequentially from $59000.0 in Q3 2019.
Coherus Oncology (CHRS) Exchange Rate Effect (2014 - 2019) Analysis & Trends
Coherus Oncology (CHRS) has 6 years of Exchange Rate Effect data on file, last reported at -$106000.0 in Q4 2019.
- For the quarter ending Q4 2019, Exchange Rate Effect fell 176.81% year-over-year to -$106000.0; the trailing twelve-month figure through Mar 2020 stood at -$140000.0 (down 140.58% YoY), and the FY2019 full-year result was -$276000.0, down 158.97% from the prior year.
- Exchange Rate Effect fell to -$106000.0 in Q4 2019, from $59000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $226000.0 in Q2 2018 to a low of -$271000.0 in Q4 2016.
- A 5-year average of -$12100.0 and a median of -$28000.0 in 2015 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect jumped 2071.43% in 2018 and tumbled 946.15% in 2019, its largest moves.
- Tracing CHRS's Exchange Rate Effect over 5 years: stood at $82000.0 in 2015, then sank by 430.49% to -$271000.0 in 2016, then jumped by 97.42% to -$7000.0 in 2017, then jumped by 2071.43% to $138000.0 in 2018, then sank by 176.81% to -$106000.0 in 2019.
- Business Quant data shows CHRS's Exchange Rate Effect at -$106000.0 in Q4 2019, $59000.0 in Q3 2019, and -$93000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Coherus Oncology | 195.05 Mn | 28.00 Mn | 8.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -106,000.00 |
| Dec 31, 2019 | -106,000.00 |
| Sep 30, 2019 | 59,000.00 |
| Sep 30, 2019 | 59,000.00 |
| Jun 30, 2019 | -93,000.00 |
| Jun 30, 2019 | -93,000.00 |
| Mar 31, 2019 | -136,000.00 |
| Mar 31, 2019 | -136,000.00 |
| Dec 31, 2018 | 138,000.00 |
| Dec 31, 2018 | 138,000.00 |
| Sep 30, 2018 | 117,000.00 |
| Sep 30, 2018 | 117,000.00 |
| Jun 30, 2018 | 226,000.00 |
| Jun 30, 2018 | 226,000.00 |
| Mar 31, 2018 | -13,000.00 |
| Mar 31, 2018 | -13,000.00 |
| Dec 31, 2017 | -7,000.00 |
| Dec 31, 2017 | -7,000.00 |
| Sep 30, 2017 | -70,000.00 |
| Sep 30, 2017 | -70,000.00 |